Reading epigenetic landscapes: New mechanisms and therapeutic opportunities.

被引：0
|
作者：
Wan, Liling [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-NG05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NG05
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A new approach for quantifying epigenetic landscapes
    Fischle, Wolfgang
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (47) : 15838 - 15839
  • [22] Editorial - Epigenetic mechanisms in oral cancer: new diagnostic and therapeutic strategies
    Scano, A.
    Casu, C.
    Orru, G.
    Coni, P.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (20) : 7318 - 7320
  • [23] Comparative genomic analysis of novel translocation renal cell carcinoma model reveals molecular mechanisms of disease progression and therapeutic opportunities.
    Prakasam, Gopinath
    Mishra, Akhilesh
    Christie, Alana
    Miyata, Jeffrey
    Tcheuyap, Vanina T.
    Ye, Hui
    Do, Quyen N.
    Jones, Kevin B.
    Requena-Komuro, Mai-Carmen
    Pedrosa, Ivan
    Rakheja, Dinesh
    Kapur, Payal
    Brugarolas, James
    [J]. CANCER RESEARCH, 2023, 83 (16)
  • [24] KRAS wild-type pancreatic ductal adenocarcinoma: Molecular and therapeutic opportunities.
    Desai, Aakash
    Walden, Daniel
    Halfdanarson, Thorvardur Ragnar
    Alberts, Steven R.
    McWilliams, Robert R.
    Mahipal, Amit
    Ahn, Daniel H.
    Babiker, Hani M.
    Tella, Sri Harsha
    McGarrah, Patrick Walsh
    Kizilbash, Sani Haider
    Adjei, Alex A.
    Bekaii Saab, Tanios S.
    Ma, Wen Wee
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] Editorial: Ferroptosis as new therapeutic targets in cancer: From molecular mechanisms to therapeutic opportunities
    Chen, Jian
    Chen, Xu
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] Chromatin profiling of glioblastoma tissues identifies core oncogenic dependency and therapeutic opportunities.
    Xu, Liang
    Chen, Ye
    Huang, Yulun
    Sandanaraj, Edwin
    Yu, John S.
    Lin, Ruby Yu-Tong
    Dakle, Pushkar
    Ke, Xin-Yu
    Chong, Yuk Kien
    Koh, Lynnette
    Mayakonda, Anand
    Nacro, Kassoum
    Hill, Jeffrey
    Huang, Mo-Li
    Gery, Sigal
    Lim, See Wee
    Huang, Zhengyun
    Xu, Ying
    Chen, Jianxiang
    Bai, Longchuan
    Wang, Shaomeng
    Wakimoto, Hiroaki
    Yeo, Tseng Tsai
    Ang, Beng Ti
    Muschen, Markus
    Tang, Carol
    Tan, Tuan Zea
    Koeffler, Phillip H.
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [27] Unraveling the mechanisms of endocrine resistance in breast cancer: New therapeutic opportunities
    Massarweh, Suleiman
    Schiff, Rachel
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (07) : 1950 - 1954
  • [28] Malaria in Pregnancy and Adverse Birth Outcomes: New Mechanisms and Therapeutic Opportunities
    Ngai, Michelle
    Weckman, Andrea M.
    Erice, Clara
    McDonald, Chloe R.
    Cahill, Lindsay S.
    Sled, John G.
    Kain, Kevin C.
    [J]. TRENDS IN PARASITOLOGY, 2020, 36 (02) : 127 - 137
  • [29] The Emerging Therapeutic Targets for Scar Management: Genetic and Epigenetic Landscapes
    Amjadian, Sara
    Moradi, Sharif
    Mohammadi, Parvaneh
    [J]. SKIN PHARMACOLOGY AND PHYSIOLOGY, 2022, 35 (05) : 247 - 265
  • [30] Hepatocyte membrane potentials and GABAergicactivity in human hepatocellular carcinoma. New insights into pathogenesis and potential diagnostic and/or therapeutic opportunities.
    Sun, DF
    Zhang, M
    Gong, YW
    Dienes, H
    Kew, M
    Minuk, GY
    [J]. HEPATOLOGY, 2003, 38 (04) : 767A - 767A
12345